Parameters Associated with v-HLNs in Whole Cohort (260 Patients) on Univariate and Multivariate Logistic Regression Analyses
| v-HLNs | ||||
|---|---|---|---|---|
| Univariate | Multivariate | |||
| Variable | P | OR | P | OR |
| Age | ||||
| ≥50 y | 0.02 | 1 (reference) | 0.04 | 1 (reference) |
| <50 y | 2.4 (1.2–4.9) | 2.2 (1.0–4.5) | ||
| Immunosuppression | ||||
| Yes | 0.86 | 1 (reference) | — | — |
| No | 0.95 (0.5–1.7) | — | ||
| Lymphopenia | ||||
| Yes | 1 (reference) | 1 (reference) | ||
| No | 0.04 | 1.9 (1.0–3.8) | 0.03 | 2.2 (1.1–4.3) |
| Unknown | 0.38 | 1.4 (0.7–2.7) | 0.37 | 1.4 (0.7–2.8) |
| Type of vaccine | ||||
| mRNA | 0.66 | 1 (reference) | — | — |
| Viral vector | 1.2 (0.5–2.7) | — | ||
| Number of vaccine dose(s) | ||||
| 1 | 0.45 | 1 (reference) | — | — |
| 2 | 1.2 (0.7–2.0) | — | ||
| Interval* | ||||
| ≥30 d | 0.02 | 1 (reference) | 0.01 | 1 (reference) |
| <30 d | 2.3 (1.2–4.9) | 2.6 (1.3–5.6) | ||
* Between last injection and PET.
Data in parentheses are 95% CIs.